SEIDENBERG BETH C received a stock award from KYVERNA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2025ACC: 0000950170-25-080457
Director10% Owner
Since Feb 2024
+81.98K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
81.98K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.63K
Price / share
—
Trade value
—
% of position
New position
5/29/2025
0.00→16.63K
Total
Net shares
+16.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2025 | A · Award | +16.63K | — | — | New position | 0.00 | 16.63K |
| Total | +16.63K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
65.35K shares
Shares
+65.35K
Strike price
2.63
Held after
65.35K
Exercisable
—
5/29/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock65.35K shares | 5/29/2025 | A · Award | +65.35K | 2.63 | — | 65.35K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned735.98K
Common Stock
IndirectShares owned3.79M
Total
4.52M indirect4.52M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 735.98K | Indirect |
| Common Stock | 3.79M | Indirect |
| Total | 4.52M | 4.52M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported